Deletion of ER-retention Motif on SARS-CoV-2 Spike Protein Reduces Cell Hybrid During Cell-cell Fusion

June 11, 2021 Leave a comment

The novel SARS-CoV-2 has rapidly develop into a world pandemic for the reason that first reported case in December 2019, with the virus infecting tens of millions of individuals to this point. The spike (S) protein of the SARS-CoV-2 virus performs a key function in binding to angiotensin-converting enzyme 2 (ACE2), a number cell receptor for SARS-CoV-2. S proteins which are expressed on the cell membrane can provoke receptor-dependent syncytia formation that’s related to intensive tissue harm. Formation of syncytia have been beforehand noticed in cells contaminated with varied different viruses (e.g., HIV, Ebola, Influenza, and Herpesviruses).

Nevertheless, this phenomenon isn’t properly documented and the mechanisms regulating the formation of those syncytia by SARS-CoV-2 aren’t totally understood. On this research, we investigated the chance that cell fusion occasions mediated by the S protein of SARS-CoV-2 and ACE2 interplay can happen in several human cell strains that mimic totally different tissue origins. These cell strains have been stably transduced with both wild-type (WT-S) S protein or a mutated variant the place the ER-retention motif was eliminated (Δ19-S), or human ACE2 vectors.

Totally different co-culture mixtures of spike-expressing 293T, A549, Ok562, and SK-Hep1 cells with hACE2-expressing cells revealed cell hybrid fusion. Nevertheless, solely sure cells expressing S protein can kind syncytial buildings as this phenomenon can’t be noticed in all co-culture mixtures. Thus, SARS-CoV-2 mediated cell-cell fusion represents a cell type-dependent course of which could depend on a distinct set of parameters. Just lately, the Δ19-S variant is being broadly used to extend SARS-CoV-2 pseudovirus manufacturing for in vitro assays.

Comparability of cell fusion occurring by way of Δ19-S expressing cells exhibits faulty nuclear fusion and syncytia formation in comparison with WT-S. This distinction between the Δ19-S variant and WT-S protein might have downstream implications for research that make the most of pseudovirus-based entry assays. Moreover, this research counsel that spike protein expressed by vaccines might have an effect on totally different ACE2-expressing host cells after SARS-CoV-2 vaccine administration. The long-term results of those vaccines must be monitored rigorously.

Molecular and Mobile Mechanisms of Respiratory Syncytial Viral An infection: Utilizing Murine Fashions to Perceive Human Pathology

Respiratory syncytial virus (RSV) causes extreme pathology of the decrease respiratory tract in infants, immunocompromised individuals, and aged. Regardless of a long time of analysis, there isn’t any licensed vaccine in opposition to RSV, and plenty of therapeutic medicine are nonetheless underneath improvement. Detailed understanding of molecular and mobile mechanisms of the RSV an infection pathology can speed up the event of efficacious therapy. Present research on the RSV pathogenesis are primarily based on the evaluation of biopsies from the contaminated sufferers; nonetheless deeper understanding of molecular and mobile mechanisms of the RSV pathology could possibly be achieved utilizing animal fashions.

Mice are essentially the most typically used mannequin for RSV an infection as a result of they exhibit manifestations much like these noticed in people (bronchial obstruction, mucous hypersecretion, and pulmonary irritation mediated by lymphocytes, macrophages, and neutrophils). Moreover, using mice is economically possible, and plenty of molecular instruments can be found for learning RSV an infection pathogenesis on the molecular and mobile ranges. This evaluation summarizes new information on the pathogenesis of RSV an infection obtained in mouse fashions, which demonstrated the function of T cells in each the antiviral protection and the event of lung immunopathology.

T cells not solely get rid of the contaminated cells, but additionally produce vital quantities of the proinflammatory cytokines TNFα and IFNγ. Just lately, a brand new subset of tissue-resident reminiscence T cells (TRM) was recognized that present a powerful antiviral protection with out induction of lung immunopathology. These cells accumulate within the lungs after native somewhat than systemic administration of RSV antigens, which suggests new approaches to vaccination. The research in mouse fashions have revealed a minor function of interferons within the anti-RSV safety, as RSV possesses mechanisms to flee the antiviral motion of kind I and III interferons, which can clarify the low efficacy of interferon-containing medicine.

Utilizing knockout mice, a major breakthrough has been achieved in understanding the function of many pro-inflammatory cytokines in lung immunopathology. It was discovered that along with TNFα and IFNγ, the cytokines IL-4, IL-5, IL-13, IL-17A, IL-33, and TSLP mediate the main manifestations of the RSV pathogenesis, equivalent to bronchial obstruction, mucus hyperproduction, and lung infiltration by pro-inflammatory cells, whereas IL-6, IL-10, and IL-27 exhibit the anti-inflammatory impact. Regardless of vital variations between the mouse and human immune methods, mouse fashions have made a major contribution to the understanding of molecular and mobile mechanisms of the pathology of human RSV an infection.

Deletion of ER-retention Motif on SARS-CoV-2 Spike Protein Reduces Cell Hybrid During Cell-cell Fusion

Competitors between RSV and influenza: Limits of modelling inference from surveillance information

Respiratory Syncytial Virus (RSV) and Influenza trigger a big burden of illness. Proof of their interplay by way of short-term cross-protection implies that prevention of 1 may inadvertently result in a rise within the burden of the opposite. Nevertheless, proof for the general public well being influence of such interplay is sparse and largely derives from ecological analyses of peak shifts in surveillance information. To check the robustness of estimates of interplay parameters between RSV and Influenza from surveillance information we carried out a simulation and back-inference research.

pPACK-SPIKE Combo Kit, includes Cat# CVD19-500A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1)
CVD19-520A-KIT 1 kit
EUR 1141

pPACK-SPIKE D614G Combo Kit, includes Cat# CVD19-530A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1)
CVD19-550A-KIT 1 kit
EUR 1141

pPACK-SPIKE N501Y Combo Kit, includes Cat# CVD19-560A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1)
CVD19-575A-KIT 1 kit
EUR 1141

pPACK-SPIKE Alpha Combo Kit, includes Cat# CVD19-590A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1)
CVD19-599A-KIT 1 kit
EUR 1141

pPACK-SPIKE Gamma Combo Kit, includes Cat# CVD19-630A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1)
CVD19-639A-KIT 1 kit
EUR 1141

pPACK-SPIKE Beta Combo Kit, includes Cat# CVD19-640A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1)
CVD19-649A-KIT 1 kit
EUR 1141

pPACK-SPIKE Delta Combo Kit, includes Cat# CVD19-650A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1)
CVD19-659A-KIT 1 kit
EUR 1141

pPACK-SPIKE Omicron Combo Kit, includes Cat# CVD19-660A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1)
CVD19-669A-KIT 1 kit
EUR 1162

pPACK-SPIKE B.1.429 Combo Kit, includes Cat# CVD19-610A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1)
CVD19-619A-KIT 1 kit
EUR 1141

pPACK-SPIKE B.1.525 Combo Kit, includes Cat# CVD19-620A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1)
CVD19-629A-KIT 1 kit
EUR 1141

Human Glucose concentration-Glucose concentration- ELISA Kit
QY-E05365 96T
EUR 400

pPACK-SPIKE B.1.351 RBD Mutations Combo Kit, includes Cat# CVD19-580A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1)
CVD19-589A-KIT 1 kit
EUR 1141

pPACK-SPIKE B.1.351 S1 Mutations Combo Kit, includes Cat# CVD19-600A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1)
CVD19-609A-KIT 1 kit
EUR 1141

Gas concentration agent
nBIONIX-A07 20
EUR 138

ETHANOL, 70% CONCENTRATION
IB15727 10L
EUR 210.13
Description: BOX W/SPIGOT (HAZ)

ddATP - high concentration
NU-271L 5 x 10µl
EUR 110.98

ddATP - high concentration
NU-271S 10µl
EUR 39.24

ddCTP - high concentration
NU-272L 5 x 10µl
EUR 110.98

ddCTP - high concentration
NU-272S 10µl
EUR 39.24

ddGTP - high concentration
NU-273L 5 x 10µl
EUR 110.98

ddGTP - high concentration
NU-273S 10µl
EUR 39.24

ddTTP - high concentration
NU-274L 5 x 10µl
EUR 110.98

ddTTP - high concentration
NU-274S 10µl
EUR 39.24

Lentivirus Concentrator
LV-CONC one kit
EUR 276.5
Description: lentivirus concentration kit

pSET152- Low concentration
PVT11339 2 ug
EUR 444

pSET152- high concentration
PVT11338 2 ug
EUR 444

Denhardt's solution, 100x Concentrate
D0062 25ml
EUR 82.97

Wash Solution Concentrate (HPE)
DS0024-125ML 1 unit
EUR 141.01
Description: Wash Solution Concentrate (HPE)

Wash Solution Concentrate (HPE)
DS0024-250ML 1 unit
EUR 280.84
Description: Wash Solution Concentrate (HPE)

Wash Solution Concentrate (50X)
WSC999 1000 ml
EUR 79.73

TEV Protease (High Concentration)
LE-002L 100000Units
EUR 3985.48

TEV Protease (High Concentration)
LE-002S 10000Units
EUR 522.55

Prewash Solution Concentrate (PW)
DS0011-400ML 1 unit
EUR 240.82
Description: Prewash Solution Concentrate (PW)

MS BASAL SALT CONCENTRATION (20x)
M576 1000ML
EUR 25.31

BD High Concentration Laminin - EACH
354259 EACH
EUR 849.15

Minimal Inhibitory Concentration Kit
K195-2500 each
EUR 836.4

Minimal Inhibitory Concentration Kit
K195-500 each
EUR 574.8

X-Gal Solution, 40 mg/ml concentrate
X0321-005 5X1ml
EUR 45

X-Gal Solution, 40 mg/ml concentrate
X0321-020 20ml
EUR 70

AvaI -HC unit: 330, High Concentration
YRAVA1-HC 1 vial Ask for price

SacI -HC unit: 1500, High Concentration
YRSAC1-HC 1 vial Ask for price

pRK2013- 1 (Low concentration) Plasmid
PVT5705 2 ug
EUR 390

Biotin-11-UTP - high concentration
NU-821-BIOX-HC 30µl
EUR 1438.95

Concentrating Solution for Sirius Red Total Collagen Detection Other
90626 50 ml
EUR 14
Description: Concentrating Solution for Sirius Red Total Collagen Detection Kit

RNA Clean-Up and Concentration Kit
23600 50 Preps
EUR 161.4

RNA Clean-Up and Concentration Kit
23640 4 Preps
EUR 12

RNA Clean-Up and Concentration Kit
43200 100 Preps
EUR 311.4

High Concentration Acid Surrogate - 1ML
CLP90-75SA 1ML
EUR 259.2

pRK2013- 2 (High concentration) Plasmid
PVT5706 2 ug
EUR 390

Biotin-11-dATP - high concentration
NU-1175-BIOX-HC 20 µL
EUR 603.29

Biotin-11-dCTP - high concentration
NU-809-BIOX-HC 500 µL
EUR 470.99

Kpn I -HC unit: 5000, High Concentration
YRKPN1-HC 1 vial Ask for price

Msp I -HC unit: 1400, High Concentration
YRMSP1-HC 1 vial Ask for price

Nco I -HC unit: 400, High Concentration
YRNCO1-HC 1 vial Ask for price

Pst I -HC unit: 12000, High Concentration
YRPST1-HC 1 vial Ask for price

Pvu II -HC unit: 2000, High Concentration
YRPVU2-HC 1 vial Ask for price

Rsa I -HC unit: 800, High Concentration
YRRSA1-HC 1 vial Ask for price

Sal I -HC unit: 2200, High Concentration
YRSAL1-HC 1 vial Ask for price

Sma I -HC unit: 1500, High Concentration
YRSMA1-HC 1 vial Ask for price

Taq I -HC unit: 410, High Concentration
YRTAQ1-HC 1 vial Ask for price

Xba I -HC unit: 3000, High Concentration
YRXBA1-HC 1 vial Ask for price

Xho I -HC unit: 5000, High Concentration
YRXHO1-HC 1 vial Ask for price

Chloride Std Solution Concentrate - 100ML
5000900C 100ML
EUR 203.85

Hi-SYBr Master Mix (Concentration 2X)
MBT074-0.5ML 1 unit
EUR 54.43
Description: Hi-SYBr Master Mix (Concentration 2X)

Hi-SYBr Master Mix (Concentration 2X)
MBT074-1ML 1 unit
EUR 104.64
Description: Hi-SYBr Master Mix (Concentration 2X)

Hi-SYBr Master Mix (Concentration 2X)
MBT074-5ML 1 unit
EUR 418.52
Description: Hi-SYBr Master Mix (Concentration 2X)

Dra I-HC unit: 3500, High Concentration
YRDRA1-HC 1 vial Ask for price

EcoR I -HC unit: 12000, High Concentration
YRECOR1-HC 1 vial Ask for price

Citrate concentrated buffer, 4% solution
GB4634 100ml
EUR 137.95

Citrate concentrated buffer, 4% solution
GB4634-100 100
EUR 45.2

Citrate concentrated buffer, 4% solution
GB4634-250 250
EUR 90.4

Citrate concentrated buffer, 4% solution
GB4634-500 500
EUR 150.7

Sperm Concentration Rapid Test Cassette
OSC-902H 1 Test
EUR 1.2

Oligo Clean-Up and Concentration Kit
34100 50 Preps
EUR 107.4

EF1a-(Red-Luciferase) Lentivirus (Zeocin), Concentrated Lentivirus
LVP1304-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: concentrated lentivirus in PBS express Red-Luciferease under EF1a promoter, containing Zeocin selection.

BamH I-HC unit: 12000, High Concentration
YRBAMH1-HC 1 vial Ask for price

Bgl II-HC unit: 2500, High Concentration
YRBGL2-HC 1 vial Ask for price

EcoR V-HC unit: 2000, High Concentration
YRECOR5-HC 1 vial Ask for price

Hind III -HC unit: 12000, High Concentration
YRHIND3-HC 1 vial Ask for price

Hinf I-HC unit: 2000, High Concentration
YRHINF1-HC 1 vial Ask for price

ViaCheck™ Concentration Control (0.5 × 106)
VC50N-20 20 mL
EUR 247.32
Description: HS Code : 38220000

ViaCheck Concentration Control 1 x 106
VC60N-20 20 ml
EUR 251.33
Description: ViaCheck Concentration Control 1 x 106 mimic the characteristics of live and dead cells in the trypan blue dye exclusion method and may be used to support validation and QC of image-based cell viability analyzers 

ViaCheck Concentration Control 4 x 106
VC70N-20 20 ml
EUR 367.48
Description: ViaCheck Concentration Control 4 x 106 mimic the characteristics of live and dead cells in the trypan blue dye exclusion method and may be used to support validation and QC of image-based cell viability analyzers 

ViaCheck Concentration Control 8 x 106
VC80N-20 20 ml
EUR 410.53
Description: ViaCheck Concentration Control 8 x 106 mimic the characteristics of live and dead cells in the trypan blue dye exclusion method and may be used to support validation and QC of image-based cell viability analyzers 

Cas9 Nuclease Protein (High Concentration)
K108 40 µg (250pmol) Volume: 25µL
EUR 80
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).;;The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants.

Presto™ Plasmid DNA Concentration Kit
PC0002 each
EUR 3

Presto™ Plasmid DNA Concentration Kit
PC0250 each
EUR 40

Presto™ Plasmid DNA Concentration Kit
PC0251 each
EUR 30

Presto™ Plasmid DNA Concentration Kit
PC0500 each
EUR 72.6

Presto™ Plasmid DNA Concentration Kit
PC0501 each
EUR 53.5

Presto™ Plasmid DNA Concentration Kit
PC1001 each
EUR 87

UPCK™ Urine Protein Concentration Kit
UPCK-10 10 preps
EUR 795

UPCK™ Urine Protein Concentration Kit
UPCK-25 25 preps
EUR 1143.6
Description: Urine Protein Enrichment Kit

UPCK™ Urine Protein Concentration Kit
UPCK-50 50 preps Ask for price

BssH II-HC unit: 200, High Concentration
YRBSSH2-HC 1 vial Ask for price

BstE II-HC unit: 1300, High Concentration
YRBSTE2-HC 1 vial Ask for price

EcoT38 I -HC unit: 900, High Concentration
YRECOT38-HC 1 vial Ask for price

Hae III-HC unit: 3400, High Concentration
YRHAE3-HC 1 vial Ask for price

Hinc II-HC unit: 500, High Concentration
YRHINC2-HC 1 vial Ask for price

EF1a-(Red-Luciferase) Lentivirus (Neomycin), Concentrated Lentivirus
LVP1234-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: concentrated lentivirus in PBS express Red-Luciferease under EF1a promoter, containing Neomycin selection.

Aminoallyl-UTP-Cy3 - high concentration
NU-821-CY3-HC 10 µL
EUR 514.84

Aminoallyl-UTP-Cy5 - high concentration
NU-821-CY5-HC 10 µL
EUR 514.84

saCas9 Nuclease Protein (High Concentration)
K144 32.5 µg (250pmol) Volume: 25µL
EUR 155
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).;;The Cas9 nuclease from the bacteria Staphylococcus aureus, abbreviated saCas9, is gaining popularity as an alternative to spCas9 due to its relatively smaller size. The saCas9 PAM sequence is 5’-NNGRRN (preferably 5’-NNGRRT).

EF1a-(Red-Luciferase) Lentivirus (Hygromycin), Concentrated Lentivirus
LVP1305-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: concentrated lentivirus in PBS express Red-Luciferease under EF1a promoter, containing Hygromycin selection.

EF1a-(Red-Luciferase) Lentivirus (Puromycin), Concentrated Lentivirus
LVP475-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: concentrated lentivirus in PBS express Red-Luciferease under EF1a promoter, containing Puromycin selection.

BCA Protein concentration determination kit
BC016-500ml 500ml
EUR 110

ViaCheck™ Concentration Control 1 x 106
24627-20 20ml
EUR 248.4

ViaCheck™ Concentration Control 4 x 106
24628-20 20ml
EUR 376.92

ViaCheck™ Concentration Control 8 x 106
24629-20 20ml
EUR 426.6

h LDOC1 (HA), Concentrated Lentivirus
LVP1132-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Premade lentivirus over-express human LDOC1 gene with N-term HA tag. It contains a RFP_Blasticidin fusion dual marker.

Cas9 Null Mutant Protein (High Concentration)
K140 40 µg (250pmol) Volume: 25µL
EUR 135
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 Null Mutant Protein is created by mutating both cleavage domains of the wild type Cas9 (D10A and H840A). Such a Cas9 protein retains its ability to bind to genomic DNA through gRNA:genomic DNA base pairing, however, unlike Cas9 Nuclease and Cas9 Nickase, where permanent gene disruption can be achieved, the Cas9 Null Mutant does not introduce any genome modifications. Therefore, this protein can provide a useful negative control for CRISPR experiments. In addition, binding of the Null Mutant can act as a roadblock to hinder transcription, thus offering a useful tool to achieve reversible knock-down of gene expression.;;The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants.

EF1a-(Red-Luciferase) Lentivirus (Blasticidin), Concentrated Lentivirus
LVP1232-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: concentrated lentivirus in PBS express Red-Luciferease under EF1a promoter, containing Blasticidin selection.

Cas9 Nuclease NLS Protein (High Concentration)
K130 40 µg (250pmol) Volume: 25µL
EUR 80
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).;;The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants. Cas9 Nuclease NLS contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein.

Cas9 Nickase D10A Protein (High Concentration)
K132 40 µg (250pmol) Volume: 25µL
EUR 135
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. One concern with the current CRISPR Cas9 technology is the potential off-target effects of the Cas9 nuclease. ;;To counteract off-target mutagenic effects of this system, the Cas9 Nickase D10A was developed with a D10A mutation in its RuvC1 nuclease domain. Unlike the Cas9 nuclease, this mutant form generates a single-stranded nick instead of a double-strand break (DSB). Because a single DNA nick is quickly repaired with high fidelity by the cellular machinery, the system requires two closely juxtaposed nicks in order to trigger the same genomic disruption as the Cas9 nuclease. This effectively boosts the recognition sequence to 40 instead of 20 nucleotides, and, as a result, off-target effects become highly unlikely. Thus, the double-nickase CRISPR system offers unparalleled specificity to satisfy even the most stringent of experimental requirements.;;The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First, the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants.

h NEUROG2 Expression Lentivirus, concentrated
LVP658-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Concentrated lentivirus express human target: NEUROG2 (neurogenin 2), containing RFP-Blasticidin dual selection

dNTP SET, Concentration: 100mM, 4x1ml set of dNTP consisting 4 separate tubes (4x1ml) each with 100mM concentration of dATP, dGTP, dCTP, and dTTP.
2013SET each
EUR 361.42

Myoglobin Concentration ELISA Quantitation Kit
GWB-E1E945 ELISA_Kits Ask for price

m Plaur (CD87), Concentrated Lentivirus
LVP1400-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: lentivirus express mouse target: Plaur (CD87), containing a RFP-Blasticidin dual selection marker.

h IL1R1 (6His), Concentrated Lentivirus
LVP1133-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Premade lentivirus over-express human IL1R1 gene with C-term 6His tag. It contains a RFP_Blasticidin fusion dual marker.

ProteoSpin™ Urine Protein Concentration Kit
17400 25 Preps
EUR 171

Cas9 Nickase H840A Protein (High Concentration)
K136 40 µg (250pmol) Volume: 25µL
EUR 135
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. One concern with the current CRISPR Cas9 technology is the potential off-target effects of the Cas9 nuclease. ;;To improve the off-target mutagenic effects of this system, the Cas9 Nickase H840A Protein was developed with a H840A mutation in its HNH-like nuclease domain. Unlike the Cas9 nuclease, this mutant form generates a single-stranded nick instead of a double-strand break (DSB). Because a single DNA nick is quickly repaired with high fidelity by the cellular machinery, the system requires two closely juxtaposed nicks in order to trigger the same genomic disruption as the Cas9 nuclease. This effectively boosts the recognition sequence to 40 instead of 20 nucleotides, and, as a result, off-target effects become highly unlikely. Thus, the double-nickase CRISPR system offers unparalleled specificity to satisfy even the most stringent of experimental requirements.;;The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First, the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants.

saCas9 Null Mutant Protein (High Concentration)
K146 32.5 µg (250pmol) Volume: 25µL
EUR 155
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The saCas9 Null Mutant Protein is created by mutating both cleavage domains of the wild type saCas9. Such a saCas9 protein retains its ability to bind to genomic DNA through sgRNA:genomic DNA base pairing, however, the saCas9 Null Mutant does not induce cleavage. Therefore, this protein can provide a useful negative control for CRISPR experiments. In addition, binding of the Null Mutant can act as a roadblock to hinder transcription, thus offering a useful tool to achieve reversible knock-down of gene expression.;;The Cas9 nuclease from the bacteria Staphylococcus aureus, abbreviated saCas9, is gaining popularity as an alternative to spCas9 due to its relatively smaller size. The saCas9 PAM sequence is 5’-NNGRRN (preferably 5’-NNGRRT).

GFP (CMV, No antibiotics) Lentivirus, Concentrated
LVP1334-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Concentrated Lentivirus express GFP under CMV promoter (Does not contain any antibioic selection.)

RFP (CMV, No antibiotics) Lentivirus, Concentrated
LVP1336-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: Concentrated Lentivirus express GFP under CMV promoter (Does not contain any antibioic selection.)

Taq DNA Polymerase (recombinant), Low Concentration - 500 U
THEP0404 each
EUR 189.66

AAVancedTM Concentration Reagent (100 ml aliquot)
AAV100A-1 100 ml
EUR 462

AAVancedTM Concentration Reagent (250 ml aliquot)
AAV110A-1 250 ml
EUR 928

asCpf1 Nuclease NLS Protein (High Concentration)
K088 38 μg (250 pmol) Volume: 25µL
EUR 75
Description: Using Cpf1 (a.k.a. Cas12a) in your CRISPR experiment offers several advantages over other CRISPR-associated nucleases.;
  • Due to the T-rich PAM sequence (TTTN), Cpf1 enables editing in regions unable to be targeted by Cas9.
  • Cpf1 can be used with a shorter guide RNA (called crRNA) than Cas9.
  • Cpf1 creates a staggered cut in dsDNA instead of a blunt cut.
  • Cpf1 cuts distal to the PAM sequence, which may allow for multiple rounds of cleavage.
      • asCpf1 is from the bacteria Acidaminococcus. This protein contains a SV40 T antigen nuclear localization signal (NLS) on the N-terminus of the protein. If the cut caused by asCpf1 is repaired by non-homologous end joining (NHEJ), an indel may be formed that disrupts the open reading frame of the targeted gene, leading to gene knockout. Alternatively, by supplying a repair template, a sequence can be knocked in at the cleavage site via homology directed repair (HDR).

saCas9 Nuclease NLS Protein (High Concentration)
K089 6.5 µg (50pmol) Volume: 50µL
EUR 55
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).;;The Cas9 nuclease from the bacteria Staphylococcus aureus, abbreviated saCas9, is gaining popularity as an alternative to spCas9 due to its relatively smaller size. The saCas9 PAM sequence is 5’-NNGRRN (preferably 5’-NNGRRT). saCas9 Nuclease NLS contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein.

fnCpf1 Nuclease NLS Protein (High Concentration)
K187 380 μg (2.5 nmol) Volume: 250µL
EUR 365
Description: Using Cpf1 (a.k.a. Cas12a) in your CRISPR experiment offers several advantages over other CRISPR-associated nucleases.;
  • Due to the T-rich PAM sequence (TTTN), Cpf1 enables editing in regions unable to be targeted by Cas9.
  • Cpf1 can be used with a shorter guide RNA (called crRNA) than Cas9.
  • Cpf1 creates a staggered cut in dsDNA instead of a blunt cut.
  • Cpf1 cuts distal to the PAM sequence, which may allow for multiple rounds of cleavage.
      • fnCpf1 is from the bacteria Francisella novicida. This protein contains a SV40 T antigen nuclear localization signal (NLS) on the N-terminus of the protein. If the cut caused by fnCpf1 is repaired by non-homologous end joining (NHEJ), an indel may be formed that disrupts the open reading frame of the targeted gene, leading to gene knockout. Alternatively, by supplying a repair template, a sequence can be knocked in at the cleavage site via homology directed repair (HDR).

asCpf1 Nuclease NLS Protein (High Concentration)
K188 380 μg (2.5 nmol) Volume: 250µL
EUR 365
Description: Using Cpf1 (a.k.a. Cas12a) in your CRISPR experiment offers several advantages over other CRISPR-associated nucleases. ;
  • Due to the T-rich PAM sequence (TTTN), Cpf1 enables editing in regions unable to be targeted by Cas9.
  • Cpf1 can be used with a shorter guide RNA (called crRNA) than Cas9.
  • Cpf1 creates a staggered cut in dsDNA instead of a blunt cut.
  • Cpf1 cuts distal to the PAM sequence, which may allow for multiple rounds of cleavage.
      • asCpf1 is from the bacteria Acidaminococcus. This protein contains a SV40 T antigen nuclear localization signal (NLS) on the N-terminus of the protein. If the cut caused by asCpf1 is repaired by non-homologous end joining (NHEJ), an indel may be formed that disrupts the open reading frame of the targeted gene, leading to gene knockout. Alternatively, by supplying a repair template, a sequence can be knocked in at the cleavage site via homology directed repair (HDR).

saCas9 Nuclease NLS Protein (High Concentration)
K189 32.5 µg (250pmol) Volume: 50µL
EUR 155
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).;;The Cas9 nuclease from the bacteria Staphylococcus aureus, abbreviated saCas9, is gaining popularity as an alternative to spCas9 due to its relatively smaller size. The saCas9 PAM sequence is 5’-NNGRRN (preferably 5’-NNGRRT). saCas9 Nuclease NLS contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein.

We developed a two-pathogen interplay mannequin, parameterised to simulate RSV and Influenza epidemiology within the UK. Utilizing the an infection mannequin together with a surveillance-like stochastic remark course of we generated a variety of doable RSV and Influenza trajectories after which used Markov Chain Monte Carlo (MCMC) strategies to back-infer parameters together with these describing competitors.

Leave a Reply

Your email address will not be published. Required fields are marked *